Insights

Strong R&D Portfolio Incyte's focus on discovering and developing first-in-class medicines in Oncology and Autoimmunity signals ongoing opportunities to introduce innovative solutions to healthcare providers specializing in these areas.

Expanding Market Approvals Recent approvals and label expansions for drugs like Minjuvi and Zynyz in Japan demonstrate growth in international markets and open doors for strategic partnerships and distribution channels.

Investment and Stake Growth Incyte's increasing stakes from institutional investors suggest confidence in its pipeline and financial stability, indicating potential for expanded collaborations or investments in new therapeutic areas.

Emerging Disease Campaigns Recent FDA and EC approvals for treatments targeting relapsed lymphoma and advanced cancers highlight opportunities to collaborate on clinical trials, patient support programs, and market entry strategies.

Market Presence and Recognition Being recognized as a top employer and loved workplace enhances Incyte’s reputation, offering opportunities to engage with their talented workforce and leverage brand trust in co-marketing or educational initiatives.

Incyte Tech Stack

Incyte uses 8 technology products and services including Apple iCloud Mail, Okta, LinkedIn Learning, and more. Explore Incyte's tech stack below.

  • Apple iCloud Mail
    Email
  • Okta
    Identity Verification
  • LinkedIn Learning
    Learning Management System
  • ServiceNow
    Miscellaneous
  • iOS
    Programming Languages
  • SAP ABAP
    Programming Languages
  • Google
    Search Engines
  • Twitter
    Widgets

Media & News

Incyte's Email Address Formats

Incyte uses at least 1 format(s):
Incyte Email FormatsExamplePercentage
FLast@incyte.comJDoe@incyte.com
90%
First.Last@incyte.comJohn.Doe@incyte.com
7%
FirstL@incyte.comJohnD@incyte.com
2%
FirstLast@incyte.comJohnDoe@incyte.com
1%

Frequently Asked Questions

What is Incyte's phone number?

Minus sign iconPlus sign icon
You can contact Incyte's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Incyte's stock symbol?

Minus sign iconPlus sign icon
Incyte is a publicly traded company; the company's stock symbol is INCY.

What is Incyte's official website and social media links?

Minus sign iconPlus sign icon
Incyte's official website is incyte.com and has social profiles on LinkedIn.

How much revenue does Incyte generate?

Minus sign iconPlus sign icon
As of December 2025, Incyte's annual revenue is estimated to be $3.7B.

What is Incyte's NAICS code?

Minus sign iconPlus sign icon
Incyte's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Incyte have currently?

Minus sign iconPlus sign icon
As of December 2025, Incyte has approximately 3.2K employees across 6 continents, including North AmericaEuropeAsia. Key team members include Ceo: P. D.Chief Medical Officer: S. S.Chief Technology Officer: D. J.. Explore Incyte's employee directory with LeadIQ.

What industry does Incyte belong to?

Minus sign iconPlus sign icon
Incyte operates in the Pharmaceutical Manufacturing industry.

What technology does Incyte use?

Minus sign iconPlus sign icon
Incyte's tech stack includes Apple iCloud MailOktaLinkedIn LearningServiceNowiOSSAP ABAPGoogleTwitter.

What is Incyte's email format?

Minus sign iconPlus sign icon
Incyte's email format typically follows the pattern of FLast@incyte.com. Find more Incyte email formats with LeadIQ.

Incyte

Pharmaceutical ManufacturingDelaware, United States1001-5000 Employees

A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs through the discovery, development and commercialization of innovative medicines.

Since 2002, Incyte has been committed to the relentless pursuit of science to improve the lives of patients and drive meaningful advances in healthcare. 

Incyte’s unique expertise in medicinal chemistry and biology has enabled us to build a portfolio of first-in-class medicines and a differentiated pipeline of therapies in Oncology and Inflammation & Autoimmunity, including Dermatology. The majority of our clinical candidates were discovered by Incyte scientists.

Headquartered in Wilmington, Delaware, Incyte has more than 2,600 employees and operations in North America, Europe and Asia. 

We are proud to have been named a top five employer by Science magazine for 7 consecutive years, as well as being named one of America’s 100 Most Loved Workplaces and one of the Most Loved Global Workplaces by Newsweek.

For additional information on Incyte, please visit Incyte.com or follow us on social media: X, Instagram, Facebook, YouTube.

See our Community Guidelines: http://bit.ly/2sV0H5W

Section iconCompany Overview

Phone number
Website
incyte.com
Stock Symbol
INCY
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
1001-5000

Section iconFunding & Financials

  • $1B$10B

    Incyte's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $1B$10B

    Incyte's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.